Eight phenolic glycosides, tachioside (1), isotachioside (2), koaburaside (3), 2,6-dimethoxy-4-hydroxyphenyl-1-O-ß-D-glucopyranoside (4), 4,6-dihydroxy-2methoxyphenyl-1-O-ß-D-glucopyranoside (5), a mixture of erigeside C (6a) and salidroside (6b), and 6-hydroxyphenyl)-1-O-ß-D-glucopyranoside (7) were isolated from the stems of Lindera obtusiloba Blume. The structures of the isolates were determined by 1 H-, 13 C-NMR, COSY, HMQC, and HMBC spectroscopy. To evaluate their anti-allergic inflammatory activities, the inhibitory effects of isolates (1-7) on histamine release and on the gene expressions of tumor necrosis factor (TNF)-α and interleukin (IL)-6 were examined using human mast cells; previous studies have reported that TNF-α and IL-6 release from mast cells is positively related to the severity of allergic symptoms. Of the tested compounds, koaburaside (3), 2,6-dimethoxy-4-hydroxyphenyl-1-O-ß-Dglucopyranoside (4), and (6-hydroxyphenyl)-1-O-ß-D-glucopyranoside (7) suppressed histamine release from mast cells as compared with gallic acid (positive control). In particular, 6-hydroxyphenyl)-1-O-ß-D-glucopyranoside (7) attenuated the gene expressions of the proinflammatory cytokines TNF-α and IL-6 in human mast cells. Our results support the notion that phenolic glycosides isolated from L. obtusiloba inhibit mast-cell-derived allergic inflammation, histamine, and proinflammatory cytokines.
Lindera obtusiloba Blume, family Lauraceae, is a traditional Korean medicine used to treat inflammation and dermatits [1a] . In addition, extracts of this plant have been reported to have antitumor, anti-allergic, and anti-inflammatory activities [1b,2a] . Previous phytochemical studies have revealed that this plant contains lignans, neolignans, flavonoids, and butanolides [2a-2c] . In our previous study, the anti-allergic inflammatory effect of the extract of L. obtusiloba was found to be due to the inhibition of histamine release and to the attenuated expression of proinflammatory cytokines [3] . Thus, we expected that isolates from this plant would exhibit anti-allergic inflammatory effects.
In order to isolate bioactive compounds from L. obtusiloba, the ethyl acetate fraction was separated by silica gel chromatography and reverse-phase preparative HPLC to afford eight phenolic glycosides, identified by a combination of spectroscopic methods as tachioside (1) This is the first report regarding the isolation of these phenolic glycosides (1-7) from L. obtusiloba. Phenolic glycosides have been extensively studied for their antioxidant [5a] , anti-HIV [5b], and anti-inflammatory activities [5c]. However, the effect of phenolic glycosides on anti-allergic inflammatory activity has not been previously examined. Isolates (1-7) were tested for their inhibitory effects on histamine release and on the gene expressions of IL-6 and TNF-α in human mast cells. In our assay system, all isolates suppressed histamine release from mast cells. In particular, 3, 4, and 7 inhibited histamine release with percentage inhibitions of 66.9, 68.1, and 65.7%, respectively, whereas gallic acid (the positive control, which has been reported to inhibit histamine release and pro-inflammatory cytokine production in mast cells [5d]) inhibited histamine generation by 65.7% at a concentration of 10 μM. In addition, 7 significantly inhibited the expressions of IL-6 and TNF-α in mast cells. Previous studies reported that reduction of TNF-α and IL-6 from mast cells is one of the key indicators of reduced allergic symptoms [5d] . Thus, the present study suggests that phenolic glycosides isolated from L. obtusiloba may be potential agents targeting anti-allergic inflammatory diseases and related disorders through depression of IL-6 and TNF-α in human mast cells.
